{"entity":{"type":"insider","cik":"0001958139","url":"/insider/0001958139","json_url":"/insider/0001958139.json","name":"Dunn Gordon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":2,"first":"2024-09-11","last":"2024-12-27","span_basis":"filed_date"},"name_variants":[{"name":"Dunn Gordon","source":"filing","n_filings":2,"first_seen":"2024-09-11","last_seen":"2024-12-27"}],"transactions":[{"id":2998749,"accession":"0001104659-24-132187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-132187","line_url":"/filing/0001104659-24-132187#line-1","is_derivative":false,"issuer_cik":"0001671502","issuer_name":"Quoin Pharmaceuticals, Ltd.","issuer_ticker":"QNRX","issuer_name_source":null,"issuer_url":"/issuer/0001671502","owner_cik":"0001958139","owner_name":"Dunn Gordon","owner_display_name":"Dunn Gordon","owner_url":"/insider/0001958139","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":122221.0,"shares_display":"122,221","price_per_share":0.45,"price_display":"0.45","price_state":"stated","total_value":54999.45,"total_display":"54,999.45","total_whole":"54,999","shares_owned_after":151077.0,"shares_owned_after_display":"151,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-23","filed_date":"2024-12-27","scope":"insider"},{"id":3232849,"accession":"0001104659-24-098940","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-098940","line_url":"/filing/0001104659-24-098940","is_derivative":false,"issuer_cik":"0001671502","issuer_name":"Quoin Pharmaceuticals, Ltd.","issuer_ticker":"QNRX","issuer_name_source":null,"issuer_url":"/issuer/0001671502","owner_cik":"0001958139","owner_name":"Dunn Gordon","owner_display_name":"Dunn Gordon","owner_url":"/insider/0001958139","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.81,"price_display":"0.81","price_state":"stated","total_value":16200.0,"total_display":"16,200.00","total_whole":"16,200","shares_owned_after":28856.0,"shares_owned_after_display":"28,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-11","scope":"insider","n_lines":2},{"id":3232845,"accession":"0001104659-24-098940","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-098940","line_url":"/filing/0001104659-24-098940","is_derivative":false,"issuer_cik":"0001671502","issuer_name":"Quoin Pharmaceuticals, Ltd.","issuer_ticker":"QNRX","issuer_name_source":null,"issuer_url":"/issuer/0001671502","owner_cik":"0001958139","owner_name":"Dunn Gordon","owner_display_name":"Dunn Gordon","owner_url":"/insider/0001958139","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8856.0,"shares_display":"8,856","price_per_share":0.79096657633243,"price_display":"0.79","price_state":"stated","total_value":7004.8,"total_display":"7,004.80","total_whole":"7,005","shares_owned_after":8856.0,"shares_owned_after_display":"8,856","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-11","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671502","name":"Quoin Pharmaceuticals, Ltd.","url":"/issuer/0001671502","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2024-09-11","last_seen":"2024-12-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001958139","retrieved_at":"2026-08-27T00:39:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}